Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The etiology of most lymphoproliferative disorders remains unclear, though several hypotheses have been proposed. One of the conjectured mechanisms is infection of a tumor clone by an oncologic virus. Recently, evidence has arisen implicating both hepatitis B and, even more so, hepatitis C viruses in the pathogenesis of lymphoproliferative disease. Based on this information, we surveyed the prevalence of hepatitis B and C virus in patients with lymphoproliferative disease. A total of 334 newly-diagnosed lymphoproliferative disease patients (200 males, 134 females) and 1,014 (133 females, 881 males) healthy controls were randomly recruited from the university blood bank. Serologic evaluation for hepatitis B and C viruses was conducted and confirmed using PCR analyses. Those with hepatitis B and/or C, controls, and subgroups of patients with lymphoproliferative disease were compared using Pearson Chi-square analysis. Among patients with lymphoid tumors, the seropositivity of HbsAg and/or anti-HCV was 8.7% (29/334), and among the controls 6.1% (49/802), however this difference did not achieve statistical significance (P = 0.23, OR: 1.36, 95% CI: 0.82–2.26). We found no significant gender- or age-related differences for either hepatitis B or C seropositivity. There were no significant differences between the seropositivity rates of hepatitis B, C, or both in either NHL or Hodgkin’s lymphoma. However, in the diffuse large cell lymphoma and follicular lymphoma subgroups, the HbsAg seropositivity rate was significantly higher than that in the controls (P = 0.017, P = 0.048, respectively), as was the seropositivity rate for hepatitis C in those with diffuse B cell lymphoma versus controls (P = 0.008). We did not identify any significant difference in the combined prevalence of hepatitis B or C seropositivity between patients with lymphoproliferative disorders and controls. However, significant differences were revealed among certain patient subgroups versus the controls. These two viruses could play a role in the development of certain specific lymphoproliferative disorders. Nevertheless, larger epidemiological studies are necessary and should focus, particulary on specific patient subgroups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gaidano G, Dalla-Favera R. Pathobiology of non-Hodgkin’s lymphomas. In: Hoffman R, Benz EJ, Shattil S, et al., editors. Hoffman: hematology: basic principles and practice. 4th ed. New York: Churchill Livingstone; 2005. p. 1307–24.

    Google Scholar 

  2. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol. 1994;88:392–4. doi:10.1111/j.1365-2141.1994.tb05036.x.

    Article  CAS  PubMed  Google Scholar 

  3. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol. 1997;19:111–29. doi:10.1007/BF00945029.

    Article  CAS  PubMed  Google Scholar 

  4. Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994;96:124–32. doi:10.1016/0002-9343(94)90132-5.

    Article  CAS  PubMed  Google Scholar 

  5. Silvestri F, Pipan C, Barillari G, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 1996;87:4296–301.

    CAS  PubMed  Google Scholar 

  6. Kuniyoshi M, Nakamuta M, Sakai H, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin’s lymphoma. J Gastroenterol Hepatol. 2001;16:215–9. doi:10.1046/j.1440-1746.2001.02406.x.

    Article  CAS  PubMed  Google Scholar 

  7. Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin’s lymphoma. Haematologica. 2006;91:554–7.

    PubMed  Google Scholar 

  8. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization: classification of tumours: tumours of haematopoietic and lymhoid tissues. Lyon: IARC Press; 2001. pp. 135–7.

  9. Kaya H, Polat MF, Erdem F, Gundogdu M. Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin’s lymphoma. Clin Lab Haematol. 2002;24:107–10. doi:10.1046/j.1365-2257.2002.00427.x.

    Article  CAS  PubMed  Google Scholar 

  10. Paydas S, Kiliç B, Sahin B, Bugdayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer. 1999;80:1303–5. doi:10.1038/sj.bjc.6690522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yenice N, Güllük F, Arican N, Turkmen S. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turk J Gastroenterol. 2003;14:173–6.

    PubMed  Google Scholar 

  12. Kocabaş E, Aksaray N, Alhan E, Tanyeli A, Koksal F, Yarkin F. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol. 1997;13:869–73. doi:10.1023/A:1007420725704.

    Article  PubMed  Google Scholar 

  13. Isikdogan A, Ayyildiz O, Dursun M, Tiftik N, Batun S, Muftuoglu E. Hepatitis C virus in patients with non-Hodgkin’s lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients. Leuk Lymphoma. 2003;44:1745–7. doi:10.1080/1042819031000116724.

    Article  PubMed  Google Scholar 

  14. Timuraglu A, Colak D, Ogunc D, Karadogan I, Undar L. Hepatitis C virus association with non-Hodgkin’s lymphoma. Haematologia (Budap). 1999;29:301–4.

    CAS  Google Scholar 

  15. Sonmez M, Bektas O, Yilmaz M, et al. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori. 2007;93:536–9.

    PubMed  Google Scholar 

  16. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004;95:745–52. doi:10.1111/j.1349-7006.2004.tb03256.x.

    Article  CAS  PubMed  Google Scholar 

  17. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078–85. doi:10.1158/1055-9965.EPI-06-0308.

    Article  CAS  PubMed  Google Scholar 

  18. Shirin H, Davidovitz Y, Avni Y, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc J. 2002;4:24–7.

    PubMed  Google Scholar 

  19. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymhoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297:2010–7. doi:10.1001/jama.297.18.2010.

    Article  CAS  PubMed  Google Scholar 

  20. Nieters A, Kallinowski B, Brennan P, et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology. 2007;132:1205–7.

    Google Scholar 

  21. De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood. 1997;90:776–82.

    PubMed  Google Scholar 

  22. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723–32. doi:10.1053/j.gastro.2003.09.025.

    Article  PubMed  Google Scholar 

  23. Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin’s lymphomas. Br J Haematol. 1996;94:544–50. doi:10.1046/j.1365-2141.1996.6912313.x.

    Article  CAS  PubMed  Google Scholar 

  24. Altıntaş A, Kaplan MA, Çil T, et al. Hepatitis B infection and its importance in cases of Hodgkin’s ve non-Hodgkin’s lyphoma. Int J Hematol Oncol. 2007;17:1–6. (in Turkish).

    Google Scholar 

  25. Olatunji PO, Okpala IE, Sorunmu MA. Hepatitis B surface antigenaemia in patients with malignant lymphoproliferative disorders. Tokai J Exp Clin Med. 1991;16:171–3.

    CAS  PubMed  Google Scholar 

  26. Galun E, Ilan Y, Livni N, et al. Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol. 1994;145:1001–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Qin XT, Lu Y, Chen XQ, Xu HP, Fan HJ. Correlation of hepatitis B virus infection to non-Hodgkin’s lymphoma. Ai Zheng. 2007;26:294–7.

    CAS  PubMed  Google Scholar 

  28. Cucuianu A, Patiu M, Duma M, et al. Hepatitis B and C virus infection in Romanian non-Hodgkin’s lymphoma patients. Br J Haematol. 1999;107:353–6. doi:10.1046/j.1365-2141.1999.01692.x.

    Article  CAS  PubMed  Google Scholar 

  29. Wang F, Xu RH, Han B, et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer. 2007;109:1360–4. doi:10.1002/cncr.22549.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Gaziantep University School of Medicine, Gaziantep, Turkey

    Vahap Okan, Mehmet Yilmaz, Cem Kis, Sami Cifci, Hakan Buyukhatipoglu & Mustafa Pehlivan

  2. Department of Microbiology and Clinical Microbiology, Gaziantep University School of Medicine, Gaziantep, Turkey

    Aysen Bayram

Authors
  1. Vahap Okan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aysen Bayram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cem Kis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sami Cifci
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hakan Buyukhatipoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mustafa Pehlivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vahap Okan.

About this article

Cite this article

Okan, V., Yilmaz, M., Bayram, A. et al. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol 88, 403–408 (2008). https://doi.org/10.1007/s12185-008-0175-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-008-0175-3

Keywords

Search

Navigation